News Release

Limitation in clinical medicine research

Anti-Cancer Agents -Volume 7

Book Announcement

Bentham Science Publishers

Frontiers in Clinical Drug Research - Anti-Cancer Agents Volume 7 is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The seventh volume of the book features reviews on these topics related to potential anti-cancer agents, Drug delivery systems and emerging immunotherapeutic strategies.

The five chapters in this volume are written by eminent authorities in the field. These chapters are the representation of the latest research progress in the use of essential oils and monoterpenes as anti cancer agents, It gives an overview of current innovative approaches to glioblastoma, focusing on the therapeutic benefits of immunotherapeutic agents and drug delivery systems. It summarizes the roles of ctDNA in clinical practice for diagnosis, treatment choices and responses to therapy in various solid cancers.It also focuses on the anti-cancer effects of pitavastatin, including its mechanism of action as well as the potential adverse reactions linked to its clinical use. The book discusses the biphasic role of cholesterol, in and around the cancer tumor, as a model target for anti-cancer therapeutic management.

Hope the readers will find these reviews valuable and thought-provoking so that they may trigger further research in the quest for new and novel therapies against cancers.

About the Editor:

Prof. Atta-ur-Rahman, Ph.D. in Organic Chemistry from Cambridge University (1968) has 1,232 international publications (45 international patents and 341 books). He received the following awards: Fellow Royal Society (FRS) London (2006), UNESCO Science Prize (1999), Honorary Life Fellow Kings College, Cambridge University (2007), Academician (Foreign Member) Chinese Academy of Sciences (2015), Highest Civil Award for Foreigners of China (Friendship Award, 2014), High Civil Award Austria (“Grosse Goldene Ehrenzeischen am Bande") (2007), Foreign Fellow Chinese Chemical Society (2013), Sc.D. Cambridge University (UK) (1987), TWAS (Italy) Prize (2009). He was the President of Network of Academies of Sciences of Islamic Countries (NASIC), Vice President TWAS (Italy), Foreign Fellow Korean Academy of Science & Technology, President Pakistan Academy of Sciences (2003-2006) and (2011 – 2014). He was the Federal Minister for Science and Technology of Pakistan (2000 – 2002), Federal Minister of Education (2002) and Chairman Higher Education Commission/Federal Minister (2002-2008), Coordinator General of COMSTECH (OIC Ministerial Committee) (1996-2012), and the Editor-in-Chief of Current Medicinal Chemistry.


Turmeric (Circuma Longa), Immunomodulatory effects,  Flaxseed, Mexican oregano (Lippia spp.) Curry leaf, Chemistry of spices Nigella sativa Food chemistry Ethnobotany enthnopharmacology


For more information Please visit :

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.